COVID-19 updates, including vaccine information, for our patients and visitors Learn More

Menu
Search

UC Board of Regents Gives Approval for New Clinical and Translational Research Institute Building on UC San Diego’s La Jolla Campus

 

November 18, 2010  |  

The University of California Board of Regents on Tuesday approved the budget for capital improvements and external financing for the Clinical and Translational Research Institute (CTRI) building, to be constructed on the medical campus of UC San Diego in La Jolla.  The CTRI building will be in close proximity to Thornton Hospital, Moores Cancer Center, the soon-to-open Sulpizio Cardiovascular Center and the recently announced Jacobs Medical Center.

“The CTRI building will create a unique multidisciplinary environment that brings together laboratory scientists and clinical investigators to understand disease, develop new methods of treatment and translate clinical research results into clinical practice,” said Gary S. Firestein, MD, professor of medicine, dean and associate vice chancellor of Translational Medicine and director of the Clinical and Translational Research Institute at UCSD School of Medicine.

The new building, currently slated for completion in late 2016, will comprise 311,000 gsf and 189,000 asf (assignable square feet) including  wet and dry research space, and clinical research space to support investigators in the School of Medicine.

The projected cost of the project is $269 million, which will be primarily paid for with external funding sources rather than state dollars, according to UC San Diego administrators.

# # #

Media Contact: Debra Kain, 619-543-6163, ddkain@ucsd.edu




Media Contact

Share This Article


Related News

7/5/2022
UC San Diego researchers found that in mice how much they ate and when altered the nature of their gut microbiome: too much food too frequently resulted in poorer microbial and metabolic health.
7/1/2022
UC San Diego researchers have created a mathematical model to help predict risk of anal cancer in persons with HIV infection and aid patients and doctors regarding screening decisions.
6/29/2022
UC San Diego Health study identifies the main job stressors contributing to physician suicides.
6/21/2022
COVID-19 rebound following Paxlovid treatment likely due to insufficient drug exposure, UC San Diego researchers find after showing rebound patient did not show drug resistance or impaired immunity.



Follow Us